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Tuberculosis (TB) remains a major global health problem, because
(i) diagnosis is usually made too late to avoid spread of infection
to contacts; (ii) vaccination with bacillus Calmette–Guérin (BCG)
does not prevent the most prevalent pulmonary disease; and (iii)
defaulting from lengthy chemotherapy leads to an increase in drug
resistant strains. The continued impact of human immunode-
ficiency virus (HIV) co-infections remains a major aggravating
factor in TB resurgence. Intensive research on the specificity and
function of immunological responses is of major importance
since protective host defense is critically dependent on T cells,
which selectively recognize only certain antigens and epitopes of
the tubercle bacillus. Such knowledge is therefore necessary for
designing a novel effective vaccine and better diagnostic tools. The
specificity of the host immune response may also help to explain
how the intracellular tubercle bacilli evade host resistance, proba-
bly by decoy pro-inflammatory actions of some of their antigens
and/or immunomodulatory constituents, which lead to chronic
infection and lung pathology.
The 12 articles in this Research Topic in the section Micro-
bial Immunology of the journal Frontiers in Immunology review
current knowledge, as well as gaps in our understanding of the
mechanisms and functions of T and B cell recognition of antigens
and constituent epitopes of Mycobacterium tuberculosis (Mtb).
The abundant occurrence of major histocompatibility complex
(MHC) class II-permissive epitopes in tubercle bacilli has impor-
tant implications for the development of both subunit vaccines
and diagnostic tests (1, 2). Moreover, an evolutionary interpre-
tation has been that selection of Mtb strains carrying protec-
tive MHC-permissive epitopes could have extended the survival
of infectious individuals and hence was advantageous for the
protracted aerosol transmission of the pathogen (1).
Better understanding of the “antigenome” of Mtb has been
advancing with the aid of new powerful strategies for the
identification of antigens and its epitope determinants. These
methods include bioinformatic approaches toward genome wide
predictive algorithms for HLA binding and high-throughput
tetramer generation (2). Hypothesis driven approaches or hypoth-
esis free searches of the whole Mtb genome and functional
screening algorithms led to the evaluation of candidate anti-
gens, which are recognized well by T cells from latently
infected individuals. They involve antigens expressed in vivo,
encoded by the DosR regulon, resuscitation promoting factor
(Rpf) proteins, and new HLA-class Ia or Ib (HLA-E) restricted
Mtb epitopes, recognized by classical and non-classical CD8 T
cells (3).
Mycobacterium tuberculosis-specific epitopes of immunodom-
inant and HLA-permissive nature have been used extensively in
IFNγ release assays (IGRAs). Several test kits can detect latent
Mtb infection with better specificity than the tuberculin based
skin test. However, these kits still need improving on their sen-
sitivity and fail to distinguish active TB from latent infection.
Moreover, biomarkers for predicting the risk of latent TB pro-
gressing into active TB are yet to be found (1, 3, 4). Further
research on possible associations between epitope specificity and
the phenotype of responding T cells could be an area of poten-
tial importance. Polyfunctional T cells have been associated with
protective immunity on the grounds that the number of T cells
producing IFNγ, IL-2, and/or tumor necrosis factor-α (TNFα) is
correlated with vaccine induced protection in models of infec-
tious diseases (4). However, the role of these cells is a subject
of debate, since they are readily detectable also in patients with
active or past TB. Although these cytokines are produced by
several cell types [CD4, CD8, TCRγδ, mucosa-associated invari-
ant T cells (MAIT), CD1-restricted T cells, and natural killer
(NK) cells], it is significant that CD4 T cell depletion cannot be
compensated with cell types other than CD4 T cells. Epitope-
specific serum antibody levels in TB patients have been found
to be influenced by the pulmonary bacterial load (associated
with HLA-DR15), recent exposure to infection, and response to
chemotherapy (5).
Identifying those antigenic determinants, which lead to host
protection, is mandatory for designing more effective vaccina-
tion strategies. A recently failed vaccine trial in children employed
Ag85A, which is highly immunogenic, but changes in its expres-
sion in infected cells could influence the susceptibility of infected
cells to host immunity (6). Hence, there is a need to select
suitable candidate antigens by more rigorous comparison of
their protective capacity in animal vaccination models, before
proceeding toward evaluation in human trials. In addition to
antigen specificity, the success of a subunit vaccine may lie
in its presentation, i.e., in the adjuvant formulation. To this
effect, the fusion of antigens with interleukins, lipids, lipopro-
teins, and immune stimulatory peptides has been employed
(7). Continued efforts to obtain better protection using recom-
binant strains of BCG engage over-expression of either Mtb-
specific antigens (which had been lost during the attenuation
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process of BCG) or of some cytokines (IL-2, IL-12, IL-15, and
GM-CSF) (8).
Although classical CD4 and CD8 T cells recognize peptide
epitopes bound to MHC, molecules with different chemical struc-
tures could be of potential importance. Thus, T cells recogniz-
ing lipid antigens may contribute to natural host protection and
might potentially be exploited for subunit based vaccination (9).
Another structural aspect is the role of post-translational mod-
ifications of proteins identified using mass spectrometry-based
proteomics (10). Recent attention to the proline–glutamic acid
(PE) family of cell surface expressed proteins has been due to their
immunomodulatory properties and possible evasion from host
immunity by antigenic variation. Immunogenicity was attributed
to the PE domain, while the specific epitopes were localized within
the polymorphic GC-rich sequence (PGRS) domain. However,
sensitization in human beings was found to be associated with
BCG vaccination, rather than latent Mtb infection (11). Appar-
ently, still other families of antigens need to be evaluated in the
search for biomarkers, which could distinguish between stable
protection and a tendency for recrudescence in latently infected
populations and also for monitoring the efficacy of protection
following prophylactic vaccination (12).
In conclusion, further research on Mtb antigen and epitope
specificities seems mandatory for realizing the crucially impor-
tant aims of both prophylactic and post exposure vaccination
against TB. Advancing the knowledge of antigenic determinants
is essential also for differentiating patients with active TB from
latently infected healthy subjects. There is potential in the ambi-
tious search for specific immunological biomarkers for predicting
the reactivation of TB in populations, both without and with HIV
infection. These endeavors will undoubtedly need to be combined
with better knowledge of the functional phenotypes of the respec-
tive T cell subsets. Other potential avenues are the construction
of fusion proteins with improved vaccine adjuvanticity (7) and
the proposed construction of T cell receptor (TCR)-like ligands
for immunotherapy (1). Future research may benefit also from
advances in computer algorithm based analysis of Mtb epitopes
and host cytokine signatures, as well as from reduced costs of
DNA and RNA sequencing and synthetic peptide libraries.
REFERENCES
1. Ivanyi J. Function and potentials of M. tuberculosis epitopes. Front Immunol
(2014) 5:107. doi:10.3389/fimmu.2014.00107
2. Lindestam Arlehamn CS, Sette A. Definition of CD4 immunosignatures associ-
ated with MTB. Front Immunol (2014) 5:124. doi:10.3389/fimmu.2014.00124
3. Geluk A, van Meijgaarden KE, Joosten SA, Commandeur S, Ottenhoff THM.
Innovative strategies to identify M. tuberculosis antigens and epitopes using
genome-wide analyses. Front Immunol (2014) 5:256. doi:10.3389/fimmu.2014.
00256
4. Prezzemolo T, Guggino G, La Manna MP, Di Liberto D, Dieli F, Caccamo N.
Functional signatures of human CD4 and CD8 T cell responses to Mycobac-
terium tuberculosis. Front Immunol (2014) 5:180. doi:10.3389/fimmu.2014.
00180
5. Bothamley GH. Epitope-specific antibody levels in tuberculosis: biomarkers of
protection, disease, and response to treatment. Front Immunol (2014) 5:243.
doi:10.3389/fimmu.2014.00243
6. Huygen K. The immunodominant T-cell epitopes of the mycolyl-transferases
of the antigen 85 complex of M. tuberculosis. Front Immunol (2014) 5:321.
doi:10.3389/fimmu.2014.00321
7. Junqueira-Kipnis AP, Marques Neto LM, Kipnis A. Role of fused Mycobacterium
tuberculosis immunogens and adjuvants in modern tuberculosis vaccines. Front
Immunol (2014) 5:188. doi:10.3389/fimmu.2014.00188
8. da Costa AC, Nogueira SV, Kipnis A, Junqueira-Kipnis AP. Recombinant BCG:
innovations on an old vaccine. Scope of BCG strains and strategies to improve
long-lasting memory. Front Immunol (2014) 5:152. doi:10.3389/fimmu.2014.
00152
9. De Libero G, Mori L. The T-cell response to lipid antigens of Mycobacterium
tuberculosis. Front Immunol (2014) 5:219. doi:10.3389/fimmu.2014.00219
10. van Els CACM, Corbière V, Smits K, van Gaans-van den Brink JAM, Poelen
MCM, Mascart F, et al. Toward understanding the essence of post-translational
modifications for the Mycobacterium tuberculosis immunoproteome. Front
Immunol (2014) 5:361. doi:10.3389/fimmu.2014.00361
11. Cohen I, Parada C,Acosta-Gío E, Espitia C. The PGRS domain from PE_PGRS33
of Mycobacterium tuberculosis is target of humoral immune response in mice
and humans. Front Immunol (2014) 5:236. doi:10.3389/fimmu.2014.00236
12. Serra-Vidal M, Latorre I, Franken KLCM, Díaz J, de Souza-Galvão ML, Casas
I, et al. Immunogenicity of 60 novel latency-related antigens of Mycobacterium
tuberculosis. Front Microbiol (2014) 5:517. doi:10.3389/fmicb.2014.00517
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 01 September 2014; accepted: 06 October 2014; published online: 23 October
2014.
Citation: Ivanyi J and Ottenhoff THM (2014) Significance of antigen and epitope
specificity in tuberculosis. Front. Immunol. 5:524. doi: 10.3389/fimmu.2014.00524
This article was submitted to Microbial Immunology, a section of the journal Frontiers
in Immunology.
Copyright © 2014 Ivanyi and Ottenhoff. This is an open-access article distributed under
the terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance with
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Immunology | Microbial Immunology October 2014 | Volume 5 | Article 524 | 2
